NO306292B1 - Triaryletylenderivater for anvendelse innen terapi - Google Patents

Triaryletylenderivater for anvendelse innen terapi

Info

Publication number
NO306292B1
NO306292B1 NO961204A NO961204A NO306292B1 NO 306292 B1 NO306292 B1 NO 306292B1 NO 961204 A NO961204 A NO 961204A NO 961204 A NO961204 A NO 961204A NO 306292 B1 NO306292 B1 NO 306292B1
Authority
NO
Norway
Prior art keywords
therapy
derivatives
agents
triarylethylene
triarylethylene derivatives
Prior art date
Application number
NO961204A
Other languages
English (en)
Norwegian (no)
Other versions
NO961204D0 (no
NO961204L (no
Inventor
Donald Paul Matthews
Alan Joseph Bitonti
William Anthony Van Sickle
Donald Alan Kaplan
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/259,797 external-priority patent/US5525633A/en
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO961204D0 publication Critical patent/NO961204D0/no
Publication of NO961204L publication Critical patent/NO961204L/no
Publication of NO306292B1 publication Critical patent/NO306292B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/20Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961204A 1993-09-24 1996-03-25 Triaryletylenderivater for anvendelse innen terapi NO306292B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12661493A 1993-09-24 1993-09-24
US08/259,797 US5525633A (en) 1993-09-24 1994-06-15 Triaryl-ethylene derivatives
PCT/US1994/009314 WO1995008528A1 (fr) 1993-09-24 1994-08-19 Derives de triarylethylene utilises therapeutiquement

Publications (3)

Publication Number Publication Date
NO961204D0 NO961204D0 (no) 1996-03-25
NO961204L NO961204L (no) 1996-03-25
NO306292B1 true NO306292B1 (no) 1999-10-18

Family

ID=26824862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961204A NO306292B1 (no) 1993-09-24 1996-03-25 Triaryletylenderivater for anvendelse innen terapi

Country Status (17)

Country Link
US (1) US5684004A (fr)
EP (1) EP0720597B1 (fr)
JP (1) JPH09503761A (fr)
CN (1) CN1131415A (fr)
AT (1) ATE165594T1 (fr)
AU (1) AU678535B2 (fr)
CA (1) CA2171728C (fr)
DE (1) DE69409961T2 (fr)
DK (1) DK0720597T3 (fr)
ES (1) ES2115975T3 (fr)
FI (1) FI961339A (fr)
HU (1) HUT75933A (fr)
IL (1) IL111018A0 (fr)
NO (1) NO306292B1 (fr)
NZ (1) NZ273433A (fr)
PL (1) PL177833B1 (fr)
WO (1) WO1995008528A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2671508B1 (fr) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Système pharma-informatique
CA2663377A1 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hepatiques par l'administration de conjugues de proteine associee au recepteur (rap)
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
JP2012526144A (ja) 2009-05-06 2012-10-25 ラボラトリー スキン ケア インコーポレイテッド 活性物質−リン酸カルシウム粒子複合体を含む経皮送達組成物およびその使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1099093A (en) * 1965-09-03 1968-01-17 Ici Ltd Alkene derivatives
DE2860900D1 (en) * 1977-08-22 1981-11-05 Ici Plc Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK0720597T3 (da) 1998-10-07
WO1995008528A1 (fr) 1995-03-30
DE69409961T2 (de) 1998-09-10
HU9600727D0 (en) 1996-05-28
NZ273433A (en) 1997-11-24
EP0720597B1 (fr) 1998-04-29
PL177833B1 (pl) 2000-01-31
AU678535B2 (en) 1997-05-29
HUT75933A (en) 1997-05-28
ATE165594T1 (de) 1998-05-15
IL111018A0 (en) 1994-11-28
ES2115975T3 (es) 1998-07-01
NO961204D0 (no) 1996-03-25
EP0720597A1 (fr) 1996-07-10
US5684004A (en) 1997-11-04
JPH09503761A (ja) 1997-04-15
DE69409961D1 (de) 1998-06-04
FI961339A0 (fi) 1996-03-22
CA2171728C (fr) 2001-11-13
FI961339A (fi) 1996-03-22
PL313594A1 (en) 1996-07-08
NO961204L (no) 1996-03-25
AU7670794A (en) 1995-04-10
CN1131415A (zh) 1996-09-18
CA2171728A1 (fr) 1995-03-30

Similar Documents

Publication Publication Date Title
MY104685A (en) Substituted thiazoles and their use as fungicides.
DE69808130D1 (de) Adamantan-derivate
DE69106714D1 (en) Hypoglykämische hydroxyharnstoffderivate.
ATE247470T1 (de) Neue substituierte imidazolverbindungen
EE200000320A (et) Uudsed ühendid
DK0711140T3 (da) Antimykotisk opløsning til negle
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
ATE115134T1 (de) 3-difluoromethylpyrazolcarboxamidfungizide.
TR200200068T2 (tr) Nematisital triflüorobütenler
ATE167670T1 (de) N-alkylthiopolyaminderivate als radioprotektive mittel
MX9201681A (es) 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas.
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
NO961204L (no) Triaryletylenderivater for anvendelse innen terapi
DE59100096D1 (de) Arbeitszylinder.
ES2152315T3 (es) Xamoneline tartrato.
NZ504614A (en) Echinocandin derivatives and application as anti-fungal agents
BR9611904A (pt) Dioxidos de ditiazol
BG101526A (en) Antiphlogistic composition for external application
ES1020705Y (es) Maquina portatil perfeccionada multiuso.
ES1024223Y (es) Unidad hermetica de uso personal.
ES1015565Y (es) Maquina portatil perfeccionada multiuso.
FIU920090U0 (fi) Borstanordning foer anslutning till en arbetsmaskins skopa
ITRM930654A0 (it) Derivati guanidinici ad uso terapeutico.